• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏舒张功能障碍可预测失代偿期肝硬化患者的预后不良。

Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis.

机构信息

Division of Hepatology, Department of Internal Medicine, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea.

出版信息

Clin Mol Hepatol. 2018 Dec;24(4):409-416. doi: 10.3350/cmh.2018.0034. Epub 2018 Aug 27.

DOI:10.3350/cmh.2018.0034
PMID:30145855
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6313020/
Abstract

BACKGROUND/AIMS: Left ventricular diastolic dysfunction (LVDD) is an early manifestation of cardiac dysfunction in patients with liver cirrhosis (LC). However, the effect of LVDD on survival has not been clarified, especially in decompensated LC.

METHODS

We prospectively enrolled 70 patients with decompensated LC, including ascites or variceal bleeding, at Daejeon St. Mary's Hospital from April 2013 to April 2015. The cardiac function of these patients was evaluated using 2D echocardiography with tissue Doppler imaging. The diagnosis of LVDD was based on the American Society of Echocardiography guidelines. The primary endpoint was overall survival.

RESULTS

Forty-four patients (62.9%) had LVDD. During follow-up (22.3 months), 18 patients died (16 with LVDD and 2 without LVDD). The survival rate was significantly lower in patients with LVDD than in those without LVDD (31.1 months vs. 42.6 months, P=0.01). In a multivariate analysis, the Child-Pugh score and LVDD were independent predictors of survival. Moreover, patients with a ratio of early filling velocity to early diastolic mitral annular velocity (E/e') ≥ 10 (LVDD grade 2) had lower survival than patients with E/e' ratio < 10.

CONCLUSION

The presence of LVDD is associated with poor survival in patients with decompensated LC. Therefore, it may be important to monitor and closely follow LVDD patients.

摘要

背景/目的:左心室舒张功能障碍(LVDD)是肝硬化(LC)患者心功能障碍的早期表现。然而,LVDD 对生存率的影响尚未明确,尤其是在失代偿性 LC 中。

方法

我们前瞻性地纳入了 2013 年 4 月至 2015 年 4 月在大田圣玛丽医院就诊的 70 例失代偿性 LC 患者,包括腹水或静脉曲张出血。这些患者的心脏功能通过二维超声心动图联合组织多普勒成像进行评估。LVDD 的诊断基于美国超声心动图学会指南。主要终点是总生存率。

结果

44 例(62.9%)患者存在 LVDD。在随访期间(22.3 个月),18 例患者死亡(16 例伴有 LVDD,2 例无 LVDD)。LVDD 患者的生存率明显低于无 LVDD 患者(31.1 个月 vs. 42.6 个月,P=0.01)。多变量分析显示,Child-Pugh 评分和 LVDD 是生存率的独立预测因素。此外,早期充盈速度与早期舒张二尖瓣环速度比(E/e')≥10(LVDD 分级 2)的患者生存率低于 E/e'比值<10 的患者。

结论

失代偿性 LC 患者存在 LVDD 与生存率降低相关。因此,监测和密切随访 LVDD 患者可能很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e2/6313020/7f1397662b22/cmh-2018-0034f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e2/6313020/74ec2000f9f0/cmh-2018-0034f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e2/6313020/77f20f2dac71/cmh-2018-0034f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e2/6313020/15b467f6be3e/cmh-2018-0034f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e2/6313020/7f1397662b22/cmh-2018-0034f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e2/6313020/74ec2000f9f0/cmh-2018-0034f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e2/6313020/77f20f2dac71/cmh-2018-0034f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e2/6313020/15b467f6be3e/cmh-2018-0034f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91e2/6313020/7f1397662b22/cmh-2018-0034f4.jpg

相似文献

1
Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis.心脏舒张功能障碍可预测失代偿期肝硬化患者的预后不良。
Clin Mol Hepatol. 2018 Dec;24(4):409-416. doi: 10.3350/cmh.2018.0034. Epub 2018 Aug 27.
2
Left Ventricular Diastolic Dysfunction is Associated with Renal Dysfunction, Poor Survival and Low Health Related Quality of Life in Cirrhosis.左心室舒张功能障碍与肝硬化患者的肾功能不全、生存率低及健康相关生活质量差有关。
J Clin Exp Hepatol. 2019 May-Jun;9(3):324-333. doi: 10.1016/j.jceh.2018.08.008. Epub 2018 Aug 30.
3
Diastolic Dysfunction Is a Predictor of Poor Survival in Patients with Decompensated Cirrhosis.舒张功能障碍是失代偿期肝硬化患者生存预后不良的一个预测指标。
Int J Hepatol. 2021 Dec 2;2021:5592376. doi: 10.1155/2021/5592376. eCollection 2021.
4
Diastolic dysfunction is a predictor of poor outcomes in patients with cirrhosis, portal hypertension, and a normal creatinine.舒张功能障碍是肝硬化、门静脉高压和肌酐正常患者预后不良的预测指标。
Hepatology. 2013 Nov;58(5):1732-41. doi: 10.1002/hep.26509. Epub 2013 Sep 30.
5
Association of left ventricular diastolic dysfunction with inflammatory activity, renal dysfunction, and liver-related mortality in patients with cirrhosis and ascites.肝硬化伴腹水患者左心室舒张功能障碍与炎症活动、肾功能障碍和肝相关死亡率的关系。
Eur J Gastroenterol Hepatol. 2024 Jun 1;36(6):775-783. doi: 10.1097/MEG.0000000000002762. Epub 2024 Mar 19.
6
Liver cirrhosis and left ventricle diastolic dysfunction: Systematic review.肝硬化与左心室舒张功能障碍:系统评价。
World J Gastroenterol. 2019 Aug 28;25(32):4779-4795. doi: 10.3748/wjg.v25.i32.4779.
7
Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis.舒张性心功能不全是肝硬化患者预后不良的一个预测指标。
Hepatol Int. 2014 Oct;8(4):588-94. doi: 10.1007/s12072-014-9544-6. Epub 2014 Jun 8.
8
Effect of left ventricular diastolic dysfunction on outcomes of atrial fibrillation ablation.左心室舒张功能障碍对房颤消融结局的影响。
Am J Cardiol. 2014 Aug 1;114(3):407-11. doi: 10.1016/j.amjcard.2014.05.012. Epub 2014 May 17.
9
Left ventricular diastolic function, assessed by echocardiography and tissue Doppler imaging, is a strong predictor of cardiovascular events, superior to global left ventricular longitudinal strain, in patients with type 2 diabetes.超声心动图和组织多普勒成像评估的左心室舒张功能是 2 型糖尿病患者心血管事件的强有力预测因子,优于整体左心室纵向应变。
Eur Heart J Cardiovasc Imaging. 2015 Sep;16(9):1000-7. doi: 10.1093/ehjci/jev027. Epub 2015 Mar 6.
10
Grading of Left Ventricular Diastolic Dysfunction with Preserved Systolic Function by the 2016 American Society of Echocardiography/European Association of Cardiovascular Imaging Recommendations Contributes to Predicting Cardiovascular Events in Hemodialysis Patients.应用 2016 年美国超声心动图学会/欧洲心血管影像协会推荐标准对左心室收缩功能正常的舒张功能不全进行分级有助于预测血液透析患者的心血管事件。
Cardiorenal Med. 2019;9(3):190-200. doi: 10.1159/000496064. Epub 2019 Mar 7.

引用本文的文献

1
H2FPEF Scores Are Increased in Patients with NASH Cirrhosis and Are Associated with Post-liver Transplant Heart Failure.H2FPEF 评分在 NASH 肝硬化患者中升高,并与肝移植后心力衰竭相关。
Dig Dis Sci. 2024 Aug;69(8):3061-3068. doi: 10.1007/s10620-024-08438-1. Epub 2024 May 23.
2
A case-cohort study of left ventricular diastolic dysfunction in patients with cirrhosis: the liver-heart axis.肝硬化患者左心室舒张功能障碍的病例队列研究:肝-心轴
Ann Gastroenterol. 2023 Nov-Dec;36(6):678-685. doi: 10.20524/aog.2023.0837. Epub 2023 Oct 30.
3
Is Cirrhotic Cardiomyopathy Related to Cirrhosis Severity?

本文引用的文献

1
Diastolic dysfunction in cirrhosis.肝硬化中的舒张功能障碍
Heart Fail Rev. 2016 Sep;21(5):599-610. doi: 10.1007/s10741-016-9552-9.
2
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.超声心动图评估左心室舒张功能的建议:美国超声心动图学会和欧洲心血管影像学会的更新
J Am Soc Echocardiogr. 2016 Apr;29(4):277-314. doi: 10.1016/j.echo.2016.01.011.
3
Diastolic Dysfunction in Liver Cirrhosis: Prognostic Predictor in Liver Transplantation?
肝硬化性心肌病与肝硬化严重程度有关吗?
Rambam Maimonides Med J. 2023 Jan 29;14(1):e0001. doi: 10.5041/RMMJ.10488.
4
Factors Predicting Cardiac Dysfunction in Patients with Liver Cirrhosis.肝硬化患者心脏功能障碍的预测因素
Middle East J Dig Dis. 2021 Jul;13(3):216-222. doi: 10.34172/mejdd.2021.228. Epub 2021 Mar 23.
5
Diastolic Dysfunction Is a Predictor of Poor Survival in Patients with Decompensated Cirrhosis.舒张功能障碍是失代偿期肝硬化患者生存预后不良的一个预测指标。
Int J Hepatol. 2021 Dec 2;2021:5592376. doi: 10.1155/2021/5592376. eCollection 2021.
6
Current Concepts of Cirrhotic Cardiomyopathy.肝硬化心肌病的现代概念。
Clin Liver Dis. 2021 May;25(2):471-481. doi: 10.1016/j.cld.2021.01.012. Epub 2021 Mar 10.
7
Direct Bilirubin Is More Valuable than Total Bilirubin for Predicting Prognosis in Patients with Liver Cirrhosis.直接胆红素比总胆红素更能预测肝硬化患者的预后。
Gut Liver. 2021 Jul 15;15(4):599-605. doi: 10.5009/gnl20171.
8
Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications.心血管介质、氧化应激和炎症在肝脏疾病及其并发症中的相互作用。
Nat Rev Cardiol. 2021 Feb;18(2):117-135. doi: 10.1038/s41569-020-0433-5. Epub 2020 Sep 30.
9
Early echocardiographic signs of diastolic dysfunction predict acute kidney injury in cirrhotic patients.早期超声心动图舒张功能障碍征象可预测肝硬化患者急性肾损伤。
J Chin Med Assoc. 2020 Nov;83(11):984-990. doi: 10.1097/JCMA.0000000000000422.
10
Syndecan-1: A Review on Its Role in Heart Failure and Chronic Liver Disease Patients' Assessment.Syndecan-1:关于其在心力衰竭和慢性肝病患者评估中作用的综述
Cardiol Res Pract. 2019 Nov 11;2019:4750580. doi: 10.1155/2019/4750580. eCollection 2019.
肝硬化中的舒张功能障碍:肝移植的预后预测指标?
Transplant Proc. 2016 Jan-Feb;48(1):128-31. doi: 10.1016/j.transproceed.2016.01.010.
4
Cirrhotic cardiomyopathy.肝硬化性心肌病
World J Gastroenterol. 2015 Nov 7;21(41):11502-21. doi: 10.3748/wjg.v21.i41.11502.
5
Diastolic dysfunction diagnosed by tissue Doppler imaging in cirrhotic patients: Prevalence and its possible relationship with clinical outcome.组织多普勒成像诊断肝硬化患者舒张功能障碍:患病率及其与临床结局的可能关系。
Eur J Intern Med. 2015 Dec;26(10):830-4. doi: 10.1016/j.ejim.2015.10.009. Epub 2015 Oct 29.
6
The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis.C反应蛋白和中性粒细胞与淋巴细胞比值对预测肝硬化住院患者预后的价值
BMC Gastroenterol. 2015 Oct 23;15:146. doi: 10.1186/s12876-015-0378-z.
7
Diastolic cardiac dysfunction is a predictor of dismal prognosis in patients with liver cirrhosis.舒张性心功能不全是肝硬化患者预后不良的一个预测指标。
Hepatol Int. 2014 Oct;8(4):588-94. doi: 10.1007/s12072-014-9544-6. Epub 2014 Jun 8.
8
B-type natriuretic peptide and cirrhosis progression.B型利钠肽与肝硬化进展
Genet Mol Res. 2015 May 18;14(2):5188-96. doi: 10.4238/2015.May.18.9.
9
Prognostic value of C-reactive protein levels in patients with cirrhosis.C反应蛋白水平在肝硬化患者中的预后价值。
Liver Transpl. 2015 Jun;21(6):753-60. doi: 10.1002/lt.24088. Epub 2015 Apr 18.
10
Cardiovascular dysfunction in patients with liver cirrhosis.肝硬化患者的心血管功能障碍
Ann Gastroenterol. 2015 Jan-Mar;28(1):31-40.